Gilead Sciences, Inc.
Gilead Sciences, Inc. is a leading American biopharmaceutical company headquartered in Foster City, California. Founded in 1987, Gilead focuses on discovering, developing, and commercializing innovative medicines in areas of unmet medical need, especially for life-threatening diseases like HIV/AIDS, liver diseases, serious respiratory and cardiovascular conditions, cancer, and inflammation. The company operates in over 35 countries across six continents and employs more than 18,000 people as of 2025, serving patients and healthcare providers globally. Gilead is listed on the NASDAQ 100 and S&P 100, and is widely recognized for its pioneering virology and oncology therapies.
Investment Strategy
Gilead Sciences does not operate as an investment fund but as a research-driven biopharmaceutical company. Its strategy centers on the discovery, development, and commercialization of innovative therapeutics that address unmet medical needs, particularly in virology, oncology, and inflammation. The company's philosophy emphasizes scientific innovation and global access, with partnerships in academia, industry, and healthcare to accelerate the development of breakthrough medicines.
Top Holdings
Equity Positions (13)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
G GLPG | GALAPAGOS NV | 36.53% | $467.6M | 16,707,477 | $27.50 | $27.99 | +$48.2M |
A ACLX | ARCELLX INC | 34.57% | $442.6M | 6,720,803 | $76.69 | $65.85 | +$1.7M |
R RCUS | ARCUS BIOSCIENCES INC | 19.98% | $255.8M | 31,424,760 | $14.58 | $8.14 | +$9.1M |
A ASMB | ASSEMBLY BIOSCIENCES INC | 3.13% | $40.0M | 2,209,471 | $15.78 | $18.12 | +$18.9M |
T TNGX | TANGO THERAPEUTICS INC | 1.94% | $24.9M | 4,854,443 | $3.09 | $5.12 | +$18.2M |